Henry Lu

Corporate Officer/Principal presso WUXI APPTEC CO., LTD.

Health Technology

Consumer Services

Profilo

Henry Lu is currently the Vice President & Head-Biology at WuXi AppTec Co., Ltd.
Prior to this, he worked as the Senior Director-Infectious Diseases at Rigel Pharmaceuticals, Inc. and as a Principal Scientist at Novartis Corp.
He also served as an Adjunct Associate Professor at The University of California, San Francisco.
Dr. Lu received his undergraduate degree from Fudan University and his doctorate from Academia Sinica.

Posizioni attive di Henry Lu

Società	Posizione	Inizio
WUXI APPTEC CO., LTD.	Corporate Officer/Principal	03/08/2011

Tutte le posizioni attive di Henry Lu

Precedenti posizioni note di Henry Lu

Società	Posizione	Fine
RIGEL PHARMACEUTICALS, INC.	Corporate Officer/Principal	-
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Corporate Officer/Principal	-
The University of California, San Francisco	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Henry Lu

Formazione di Henry Lu

Fudan University	Undergraduate Degree
Academia Sinica	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Henry Lu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
RIGEL PHARMACEUTICALS, INC.	Health Technology
WUXI APPTEC CO., LTD.	Health Technology

Aziende private	1
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Health Technology

Vedi le connessioni aziendali